Baricitinib for the treatment of rheumatoid arthritis

Baricitinib for the treatment of rheumatoid arthritis

Rheumatoid arthritis (RA) is a common inflammatory disease with several implications on health, disability and economy. Conventional treatment for RA centers on anti-inflammatory drugs and specific targeting of tumor necrosis factor  (TNF-) and interleukin 6 (IL-6). Baricitinib is a novel, Food an...

Full description

Saved in:
Bibliographic Details
Main Authors: Ivan Urits, Jacob Israel, Hayk Hakobyan, George Yusin, Grace Lassiter, Nathan Fackler, Amnon A. Berger, Hisham Kassem, Alan Kaye, Omar Viswanath
Format: article
Language:EN
Published: Termedia Publishing House 2020
Subjects:
rheumatoid arthritis
novel treatment
baricitinib
janus kinase/signaling transducer and activator of transcription
kinase inhibitor.
Medicine
R
Online Access:https://doaj.org/article/efa1b6f0f94641f0bc847beee18fbe9b
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/efa1b6f0f94641f0bc847beee18fbe9b

Similar Items